Clinical Trial Update: Milademetan in Advanced/Metastatic Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial of milademetan in advanced or metastatic solid tumors was terminated, with results posted in October 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Gastric Cancer
• Head and Neck Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Milademetan (milademetan)

Snippet

Sponsor: Rain Oncology Inc | Conditions: Solid Tumors, Head and Neck Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-10-17